The burden of group A streptococcal pharyngitis in Melbourne families

Indian Journal of Medical Research, Supplement

Volumn 119, Issue MAY, 2004, Pages 144-147

  Danchin, Margaret H ^a,b,c   Rogers, Susan ^b   Selvaraj, Gowri ^b   Kelpie, Loraine ^a   Rankin, Peter ^d   Vorich, Robert ^d   Howson, Michael ^d   Carlin, John B ^a,b,c   Curtis, Nigel ^a,b,c   Nolan, Terrence M ^c   Carapetis, Jonathan R ^a,b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d School of Population Health ^*

Author keywords

Group A streptococcal; Melbourne; Pharyngitis

Indexed keywords

ANTIBIOTIC AGENT; ANTISTREPTOLYSIN; STREPTOCOCCUS VACCINE; STREPTODORNASE;

ABSENTEEISM; ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; COST OF ILLNESS; DISEASE CARRIER; FAMILIAL DISEASE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHARYNGITIS; PROSPECTIVE STUDY; SEROLOGY; SPRING; STREPTOCOCCUS GROUP A; STREPTOLYSIN TITER; SUMMER; THROAT CULTURE; WINTER;

COHORT STUDIES; HUMANS; INCIDENCE; PHARYNGITIS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VICTORIA;

EID: 3442889105     PISSN: 03679012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. National Prescribing Service. Antibiotics in primary care. Prescribing practice review (PPR 18). Surey Hills, Australia: National Prescribing Service Limited; 2002; 18: p 2-3.
2. Britt H, Miller GC, Knox S, Charles J, Valenti L, Henderson J, et al. General practice activity in Australia 2000-2001. Canberra: Australian Institute of Health and Welfare (AIHW Catalogue No.GEP 8), 2001. General Practice Series no.8.
3. Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat. Cochrane Database Systematic Reviews 2001: 2.
4. Hu MC, Walls MA, Stroup SD, Reddish MA, Beall B, Dale JB. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun 2002; 70: 2171-7.
5. Shulman S, Tanz RR, Gerber MA. Streptococcal pharyngitis. In: Stevens D, Kaplan EL, editors. Streptococcal infections: clinical aspects, microbiology, and molecular pathogenesis. New York: Oxford University Press; 2000 p. 76-101.
6. Rantz LA. Randall E. A modification of the technique for determination of the anti-streptolysin o titer. Proc Soc Exp Biol Med 1945; 59: 22-5.
7. Johnson DR, Kaplan EL. Determination of anti-streptolysin O. In: Johson DR, Kaplan EL, editors. Laboratory diagnosis of group A streptococcal unfections. Geneva: World Health Organization, 1996.
8. Dingle JF, Badger GF, Jordan WS. Streptococcal infections. Illness in the home: a study of 25,000 illnesses in a group of Cleveland families. Cleveland: Press of Western Reserve University; 1964 p. 97-117.
9. Breese BB, Dicney FA, Talpey W. The nature of a small pediatric group practice 1. Pediatrics 1966; 38: 264-77.
10. Cornfeld D, Hubbard JP, Harris TN, Weaver R. Epidemiologic studies of streptococcal infection in school children. Am J Public Health 1961; 51: 242-9.
11. Lennon D. Rheumatic fever: a preventable disease? The New Zealand experience. Streptococci and streptococcal diseases: entering the new millenium. Porirua: ESR; 2000 p. 503-12.
12. Nandi S, Kumar R, Ray P, Vohra H, Ganguly NK. Group A streptococcal sore throat in a periurban population of northern India: a one-year prospective study. Bull World Health Organ 2001; 79: 528-33.